Based on the developmental sequence of hematopoiesis shown in the figure, which of the following statements is most accurate regarding the transition of erythropoiesis during fetal life?
---
- (A) Definitive erythropoiesis begins only after hematopoiesis is fully established in the bone marrow
- (B) Yolk sac–derived hematopoiesis contributes to all hematopoietic lineages throughout fetal life
- (C) Liver becomes the predominant site of erythropoiesis before bone marrow hematopoiesis is fully established
- (D) Bone marrow becomes the major site of hematopoiesis before the peak of hepatic erythropoiesis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Liver becomes the predominant site of erythropoiesis before bone marrow hematopoiesis is fully established)
Hematopoiesis during development follows a well-defined temporal and spatial sequence, which is essential for understanding many neonatal and fetal hematologic conditions. Initially, primitive erythropoiesis begins in the yolk sac, producing mainly erythroid cells with limited lineage potential. This is followed by the emergence of definitive hematopoiesis, with early progenitors arising in the aortogonadomesonephron region and subsequently colonizing the fetal liver. The liver then becomes the predominant site of hematopoiesis, producing all major hematopoietic lineages and reaching peak erythropoietic activity between 5 to 6 months of gestation. Although bone marrow hematopoiesis begins around 8 weeks of gestation, it takes several weeks to become fully established and only becomes the major site later in gestation. Therefore, there is a significant period during which the liver is the dominant hematopoietic organ before bone marrow takes over, making this transition a key developmental concept.
![[a52e4c4c_1776160263767_1776160264.png]]
Which of the following components of the hypoxia-inducible factor (HIF) complex is primarily oxygen sensitive and regulates erythropoietin production?
---
- (A) HIF-1β
- (B) HIF-2β
- (C) HIF-α
- (D) Prolyl hydroxylase
💡 Click to Reveal Answer & Nelson Rationale
Option C (HIF-α)
The hypoxia-inducible factor complex is the key regulator of erythropoietin production in response to oxygen levels. It consists of two subunits, an alpha and a beta subunit. The beta subunit is constitutively expressed and remains stable regardless of oxygen concentration. In contrast, the alpha subunit is highly sensitive to oxygen levels and determines the activity of the complex. Under normoxic conditions, HIF-α is hydroxylated by prolyl hydroxylase enzymes and rapidly degraded. During hypoxia, this degradation is inhibited, leading to stabilization and accumulation of HIF-α, which then translocates to the nucleus, dimerizes with HIF-β, and activates transcription of erythropoietin. Therefore, HIF-α is the primary oxygen-sensitive component regulating erythropoietin production.
Which of the following cell types arises from the common myeloid progenitor via CFU-MK?
---
- (A) T lymphocyte
- (B) Platelets
- (C) Natural killer cell
- (D) Plasma cell
💡 Click to Reveal Answer & Nelson Rationale
Option B (Platelets)
Hematopoiesis begins with pluripotent hematopoietic stem cells, which differentiate into two major lineages: myeloid and lymphoid progenitors. The myeloid lineage gives rise to erythrocytes, granulocytes, monocytes, and megakaryocytes. Megakaryocyte development proceeds through colony-forming unit–megakaryocyte (CFU-MK), which further matures into megakaryocytes that fragment to form platelets. This pathway is distinct from the lymphoid lineage, which produces T cells, B cells, and natural killer cells. The diagram highlights that platelets are derived specifically from megakaryocytes in the myeloid lineage, making CFU-MK a key intermediate in platelet production.
A term neonate has laboratory evaluation showing decreased levels of antithrombin III compared to adults. Despite this, the infant does not develop spontaneous thrombosis due to compensatory increase in which of the following anticoagulant proteins?
---
- (A) Protein C
- (B) Protein S
- (C) Alpha2-macroglobulin
- (D) Antithrombin III
💡 Click to Reveal Answer & Nelson Rationale
Option C (Alpha2-macroglobulin)
Neonatal hemostasis is characterized by a balanced but developmentally distinct system compared to adults. Although several natural anticoagulants such as antithrombin III, Protein C, and Protein S are decreased in neonates, thrombosis does not commonly occur because of compensatory mechanisms. One key compensatory factor is the increased level of alpha2-macroglobulin, a broad-spectrum protease inhibitor with anticoagulant properties. It helps regulate thrombin and other proteases, thereby maintaining hemostatic balance despite reduced levels of other anticoagulants. This explains why neonates can maintain effective hemostasis even with quantitatively lower levels of multiple coagulation inhibitors.
![[9dfd288f_small__21__1777058246.png]]
Which of the following correctly matches the anticoagulant with the coagulation factors it primarily inhibits?
---
- (A) Antithrombin III – Factors II, IX, X; Protein C – Factors V and VIII
- (B) Antithrombin III – Factors IX, X, XI; Protein C – Factors VIII and X
- (C) Antithrombin III – Factors II, IX, X; Protein C – Factors V and IX
- (D) Antithrombin III – Factors IX, X, XI; Protein C – Factors V and VIII
💡 Click to Reveal Answer & Nelson Rationale
Option D (Antithrombin III – Factors IX, X, XI; Protein C – Factors V and VIII)
The anticoagulant pathways in coagulation are highly specific and often tested with closely related options. Antithrombin III inhibits activated coagulation factors, especially thrombin (factor IIa) and factors IXa, Xa, and XIa, thereby limiting clot propagation. Protein C, along with its cofactor protein S, specifically inactivates factors Va and VIIIa, which are essential cofactors in thrombin generation. The confusion often arises because both systems regulate clotting but act on different targets within the cascade. Correct differentiation requires remembering that antithrombin targets activated enzymes, while protein C targets cofactors.
Regarding neonatal thrombocytopenia secondary to maternal immune thrombocytopenic purpura (ITP), which of the following statements is incorrect?
---
- (A) Mild thrombocytopenia at birth warrants repeat platelet count at 2–3 days due to nadir between days 2–5
- (B) Neonatal thrombocytopenia may persist for weeks to months and may require repeat IVIG at 4–6 weeks
- (C) Cranial imaging should be performed when platelet count is <50,000/μL
- (D) IVIG is indicated when platelet count is <50,000/μL
💡 Click to Reveal Answer & Nelson Rationale
Option D (IVIG is indicated when platelet count is <50,000/μL)
Neonatal thrombocytopenia due to maternal ITP has a predictable temporal pattern and defined management thresholds. First, platelet counts often decline after birth and reach a nadir between days 2–5, so even mild thrombocytopenia at birth must be followed with repeat counts. Unlike NAIT, this condition is more prolonged—platelet recovery may take weeks to months, and some infants may require repeat IVIG at 4–6 weeks.
Second, risk of intracranial hemorrhage increases as platelet count falls, and therefore cranial imaging is recommended when platelet count is <50,000/μL, even in asymptomatic infants (C is correct).
The key distinction is the treatment threshold for IVIG. Standard indication is platelet count <30,000/μL, reflecting higher bleeding risk. While IVIG may be considered in the 30–50 × 10⁹/L range in selected stable infants to prevent further decline, this is not a strict indication. Therefore, stating that IVIG is indicated at <50,000/μL is incorrect.
In the management of congenital platelet function disorders in neonates, which of the following strategies is most appropriate?
---
- (A) Platelet transfusions should be used early in the disease course to prevent alloimmunization-related refractoriness
- (B) Desmopressin is preferred over platelet transfusion in neonates due to lower risk of volume overload
- (C) Recombinant activated factor VII (rFVIIa) should be used in severe platelet function defects before other therapies
- (D) Platelet transfusions should be restricted to life-threatening bleeding due to risk of antibody formation against platelet glycoproteins
💡 Click to Reveal Answer & Nelson Rationale
Option D (Platelet transfusions should be restricted to life-threatening bleeding due to risk of antibody formation against platelet glycoproteins)
Management of congenital platelet function disorders in neonates requires balancing immediate hemostasis with long-term consequences. In conditions like Bernard-Soulier and Glanzmann thrombasthenia, platelet transfusions can lead to alloimmunization against platelet glycoproteins (GPIb, GPIIb/IIIa). Once antibodies develop, future transfusions become ineffective, making this a critical limitation. Therefore, platelet transfusions should be reserved only for life-threatening bleeding, rather than used early or liberally.
Desmopressin is not recommended in neonates due to risk of hyponatremia and seizures. rFVIIa, although effective, is reserved for severe bleeding refractory to standard measures, given its risk of thrombosis, and is not used before other therapies.
Which of the following best describes a major limitation of the Kleihauer-Betke test in accurately quantifying fetomaternal hemorrhage?
---
- (A) Reduced sensitivity in detecting fetal erythrocytes when the volume of hemorrhage exceeds 1% of maternal blood volume due to saturation of staining capacity
- (B) Inability to distinguish fetal erythrocytes in conditions where maternal red cells contain increased hemoglobin F, leading to erroneous overestimation of fetal cells
- (C) Dependence on antigen–antibody interactions, resulting in reduced accuracy in Rh-negative mothers lacking D antigen expression
- (D) Rapid clearance of fetal erythrocytes from maternal circulation in all cases, resulting in consistent underestimation of hemorrhage volume
💡 Click to Reveal Answer & Nelson Rationale
Option B (Inability to distinguish fetal erythrocytes in conditions where maternal red cells contain increased hemoglobin F, leading to erroneous overestimation of fetal cells)
The Kleihauer-Betke (KB) test relies on differential elution of hemoglobin A, with HbF-containing cells (fetal RBCs) retaining stain.
**The key limitation arises when:**
The mother has elevated HbF levels (e.g., sickle cell disease, β-thalassemia, HPFH)
Maternal RBCs also retain stain, mimicking fetal cells
This leads to inaccurate quantification (often overestimation) of fetomaternal hemorrhage
**Additional nuances:**
Even relatively small fetal blood losses (>1% maternal volume) are detectable
ABO incompatibility may lead to rapid clearance of fetal RBCs → underestimation
Flow cytometry offers improved accuracy but is less widely available
A term neonate is evaluated at birth, and hemoglobin composition is analyzed. Based on these, which of the following globin chains are present at birth contributing to hemoglobin composition?
---
- (A) Alpha, gamma, beta, epsilon, zeta and with trace delta chains
- (B) Alpha, gamma, beta, epsilon, zeta chains with negligible delta chains
- (C) Alpha, gamma, beta chains with trace delta chains
- (D) Alpha, gamma, and beta chains with negligible delta chains
💡 Click to Reveal Answer & Nelson Rationale
Option C (Alpha, gamma, beta chains with trace delta chains)
At birth, hemoglobin composition is predominantly HbF (α2γ2), with a smaller proportion of HbA (α2β2) and trace amounts of HbA2 (α2δ2). Therefore, the globin chains present include alpha and gamma as the major components, along with beta chains beginning to increase near term and delta chains present only in trace amounts. The figure shows that embryonic globin chains such as epsilon and zeta are expressed early in gestation and disappear before birth. Gamma chains remain high at birth, while beta chains rise around term. Delta chains are present but minimal, contributing only to a very small fraction of hemoglobin. Thus, the correct combination includes alpha, gamma, beta, and trace delta chains without embryonic chains.
![[ebdff595_1776328756339_1776328758.png]]
![[34f6d53a_small__20__1777056977.png]]
Which of the following statements best describes the functional characteristic of innate lymphoid cells (ILCs) in response to pathogenic signals?
---
- (A) ILCs are terminally differentiated cells with fixed phenotype and function
- (B) ILC subsets exhibit plasticity and can change phenotype and function depending on environmental signals
- (C) ILCs function exclusively as antigen-presenting cells similar to dendritic cell
- (D) ILCs require antigen-specific receptors for activation and differentiation
💡 Click to Reveal Answer & Nelson Rationale
Option B (ILC subsets exhibit plasticity and can change phenotype and function depending on environmental signals)
Innate lymphoid cells are a group of lymphoid-derived immune cells that function as part of the innate immune system. Unlike adaptive immune cells, they lack antigen-specific receptors but can rapidly respond to environmental cues. Recent findings have demonstrated that ILC subsets are not fixed in their identity; instead, they exhibit functional plasticity, allowing them to change their phenotype and cytokine profile depending on specific pathogenic or inflammatory signals. This adaptability enables ILCs to tailor immune responses according to the type of pathogen encountered, making them important regulators of immune homeostasis and inflammation.
A preterm neonate admitted in NICU receives multiple packed red blood cell transfusions during hospitalization. Which of the following conditions is NOT associated with increased number of RBC transfusions in such infants?
---
- (A) Bronchopulmonary dysplasia
- (B) Necrotizing enterocolitis
- (C) Retinopathy of prematurity
- (D) Persistent pulmonary hypertension of newborn
💡 Click to Reveal Answer & Nelson Rationale
Option D (Persistent pulmonary hypertension of newborn)
Multiple RBC transfusions in preterm infants have been associated with several adverse outcomes in retrospective and observational studies. These include bronchopulmonary dysplasia, necrotizing enterocolitis, retinopathy of prematurity, increased diuretic requirement, and poorer neurodevelopmental outcomes. The underlying mechanisms involve oxidative stress, iron overload, inflammatory mediator accumulation, and impaired microcirculation due to storage lesions in transfused RBCs. These effects particularly damage developing organs such as lungs, retina, and intestine, which are highly vulnerable in preterm infants. However, persistent pulmonary hypertension of the newborn is not associated with repeated transfusions and instead results from failure of normal pulmonary vascular transition after birth, typically due to perinatal hypoxia, lung pathology, or meconium aspiration.
A 28-week gestation preterm neonate (birth weight 900 g) is on day 12 of life in the NICU. The infant initially required ventilatory support for respiratory distress syndrome but is now stable on minimal oxygen. There is no evidence of active bleeding, no recent invasive procedures, and vital parameters are stable. Routine laboratory evaluation reveals a platelet count of 29,000/μL. What is the most appropriate next step in management?
---
- (A) Immediate platelet transfusion
- (B) Observe and repeat platelet count after 24 hours
- (C) Transfuse only if platelet count falls below 50,000/μL
- (D) Start prophylactic platelet transfusion irrespective of clinical status
💡 Click to Reveal Answer & Nelson Rationale
Option A (Immediate platelet transfusion)
Platelet transfusion thresholds in preterm neonates depend on postnatal age and clinical stability, with a shift toward restrictive strategies to reduce transfusion-related harm. During the first week of life, a higher threshold of 50,000/μL is used due to bleeding risk, but after the first week, prophylactic transfusions are avoided unless platelet count falls below 30,000/μL in stable, non-bleeding infants. In this case, the neonate is on day 12 with a platelet count of 29,000/μL, which meets the transfusion threshold. Evidence from trials shows that higher transfusion thresholds lead to more transfusions and worse outcomes, including increased mortality, despite fewer bleeding events, indicating harmful effects of transfusions such as inflammation and immune modulation. Standard practice uses single donor platelets (10–20 mL/kg), which raise platelet count by >100,000/μL and may persist for about one week, while pooled or volume-reduced platelets are avoided due to reduced function. Thus, a restrictive threshold with appropriate transfusion at <30,000/μL balances bleeding risk and transfusion-related complications.
A 6-day-old term neonate presents with bleeding from venipuncture sites and mild gastrointestinal bleeding. The infant received vitamin K prophylaxis at birth. Examination reveals jaundice and hepatomegaly. Laboratory evaluation shows prolonged PT and APTT, normal platelet count, and decreased fibrinogen levels. D-dimer levels are mildly elevated. Which of the following is the most likely diagnosis?
---
- (A) Hemorrhagic disease of the newborn
- (B) Disseminated intravascular coagulation
- (C) Liver disease
- (D) von Willebrand disease
💡 Click to Reveal Answer & Nelson Rationale
Option C (Liver disease)
This neonate presents with a mixed coagulation defect characterized by prolonged PT and APTT along with decreased fibrinogen, indicating impaired synthesis of multiple clotting factors. The presence of jaundice and hepatomegaly strongly suggests underlying hepatic dysfunction. The liver is responsible for synthesis of most coagulation factors including fibrinogen and vitamin K–dependent factors, so liver disease leads to global reduction in these factors. Normal platelet count helps differentiate it from disseminated intravascular coagulation, where thrombocytopenia is expected due to consumption. Mild elevation of D-dimer can occur in liver disease due to impaired clearance rather than true consumptive coagulopathy. Prior vitamin K administration rules out hemorrhagic disease of the newborn. von Willebrand disease does not affect PT and typically presents with normal coagulation studies except for platelet function abnormalities. Thus, the combination of clinical features and laboratory findings points toward liver disease as the most likely diagnosis.
![[b620faee_large__1__1776170620.png]]
A preterm neonate with an umbilical arterial catheter develops dusky discoloration of the toes. The limb is cool but pulses are palpable. Discoloration persists despite warming of the contralateral limb for 15 minutes, but there is no progression to necrosis or loss of pulses. What is the most appropriate next step in management?
---
- (A) Immediate catheter removal
- (B) Continue close monitoring
- (C) Local application of 2% nitroglycerin
- (D) Initiate thrombolysis
💡 Click to Reveal Answer & Nelson Rationale
Option C (Local application of 2% nitroglycerin)
This scenario represents persistent peripheral vasospasm that does not resolve with initial conservative management such as contralateral limb warming. The presence of palpable pulses and absence of necrosis suggest that arterial thrombosis has not yet occurred. According to the management flowchart, if vasospasm persists after warming, the next step is local application of 2% nitroglycerin ointment, which acts as a vasodilator and improves local blood flow. Blood pressure should be monitored closely during its use. The image-based flowchart highlights this stepwise escalation from warming to topical therapy before considering catheter removal or more aggressive interventions.
![[821f7259_1776170959709_1776170960.png]]
A term neonate born to a mother with gestational diabetes presents on day 2 of life with gross hematuria and irritability. Examination reveals a palpable abdominal mass. Laboratory findings show thrombocytopenia and rising serum creatinine. Doppler ultrasound demonstrates renal vein thrombosis with extension into the inferior vena cava. What is the most appropriate management?
---
- (A) Anticoagulation alone without thrombolysis
- (B) Initial thrombolysis followed by anticoagulation
- (C) Observation with delayed anticoagulation if progression occurs
- (D) Supportive care with serial monitoring only
💡 Click to Reveal Answer & Nelson Rationale
Option B (Initial thrombolysis followed by anticoagulation)
This is a severe presentation of renal vein thrombosis with extension into the inferior vena cava and associated renal dysfunction. The key factor guiding management is the presence of end-organ compromise and thrombus extension. While uncomplicated RVT is treated with anticoagulation alone, cases with extension into major vessels or renal failure require more aggressive therapy. In such situations, initial thrombolysis with rt-PA is indicated to rapidly restore perfusion, followed by anticoagulation to prevent recurrence. The differentiation between anticoagulation alone and thrombolysis depends on severity.
![[6c4fc55f_medium_1776171319.png]]
A 30-week preterm neonate with catheter-related venous thrombosis is started on unfractionated heparin infusion. After initial stabilization, the team plans to switch to low-molecular-weight heparin (LMWH) for maintenance therapy. What is the most appropriate LMWH dosing regimen in this infant?
---
- (A) 0.75 mg/kg subcutaneously every 12 hours
- (B) 1 mg/kg subcutaneously every 12 hours
- (C) 1.5 mg/kg subcutaneously every 12 hours
- (D) 2 mg/kg subcutaneously every 12 hours
💡 Click to Reveal Answer & Nelson Rationale
Option C (1.5 mg/kg subcutaneously every 12 hours)
LMWH dosing in neonates is dependent on gestational age due to differences in pharmacokinetics and antithrombin levels. In preterm infants ≤32 weeks gestation, higher doses are required to achieve therapeutic anti-Xa levels. The recommended dose in this group is 1.5 mg/kg subcutaneously every 12 hours. In contrast, infants >32 weeks require 2 mg/kg every 12 hours. The lower dose of 0.75 mg/kg every 12 hours represents prophylactic dosing rather than therapeutic dosing.
![[905eec54_medium_1776238142.png]]
A term neonate presents within 6 hours of life with petechiae and a platelet count of 24,000/μL. The infant is clinically stable with no evidence of intracranial hemorrhage. Neonatal alloimmune thrombocytopenia (NAIT) is suspected. What is the most appropriate initial management?
---
- (A) Start IVIG alone at 1 g/kg/day for 2 days
- (B) Transfuse random donor platelets
- (C) Wait for antigen-negative platelets before initiating therapy
- (D) Maintain platelet count >100 × 10⁹/L with aggressive transfusions
💡 Click to Reveal Answer & Nelson Rationale
Option B (Transfuse random donor platelets)
In suspected NAIT, random donor platelet transfusion is the first-line therapy, as a significant proportion of neonates respond to these platelets. In clinically stable infants without intracranial hemorrhage, transfusion is generally initiated when platelet count is <30 × 10⁹/L. Although IVIG can be added to increase endogenous platelet production and protect transfused platelets, it is not the initial standalone therapy.
Waiting for antigen-negative platelets may delay urgent treatment and increase the risk of bleeding. However, arrangements should be made early with the blood bank to secure antigen-negative platelets (e.g., HPA-1b1b or maternal platelets) in case the infant does not respond to initial therapy. Maintaining platelet counts >100 × 10⁹/L is indicated only in cases with intracranial hemorrhage.
A term neonate presents on day 3 of life with generalized petechiae and excessive bleeding following circumcision. There is no history of maternal thrombocytopenia. Laboratory evaluation reveals a platelet count of 85,000/μL with normal PT and aPTT. Peripheral smear shows large platelets. Platelet function testing demonstrates defective aggregation with ristocetin, which does not correct with the addition of normal plasma, while aggregation with ADP and collagen is relatively preserved. What is the most likely diagnosis?
---
- (A) Glanzmann thrombasthenia
- (B) von Willebrand disease
- (C) Bernard-Soulier syndrome
- (D) Gray platelet syndrome
💡 Click to Reveal Answer & Nelson Rationale
Option C (Bernard-Soulier syndrome)
This is a high-yield confusing scenario mimicking both von Willebrand disease and Glanzmann thrombasthenia. The presence of mucocutaneous bleeding with normal PT/aPTT points toward a platelet disorder. The defective ristocetin-induced aggregation initially suggests either vWD or Bernard-Soulier syndrome.
**The key differentiating features are:**
Macrothrombocytopenia (low platelet count with large platelets) → favors Bernard-Soulier syndrome
Failure of correction with normal plasma → indicates a platelet receptor defect (GPIb) rather than vWF deficiency
Thus, the findings are consistent with Bernard-Soulier syndrome, caused by GPIb deficiency leading to impaired platelet adhesion.
A 900 g preterm neonate born to a CMV-seronegative mother requires multiple packed RBC transfusions in the NICU. The treating team wants to minimize the risk of transfusion-transmitted CMV infection while ensuring adequate blood availability.
Which of the following is the most appropriate strategy?
---
- (A) Use only CMV-seronegative donor blood for all transfusions
- (B) Use leukocyte-reduced packed RBCs for transfusion
- (C) Use fresh whole blood to minimize viral transmission
- (D) Avoid transfusion unless absolutely life-threatening
💡 Click to Reveal Answer & Nelson Rationale
Option B (Use leukocyte-reduced packed RBCs for transfusion)
Preterm infants, especially those <1250 g and born to CMV-seronegative mothers, are at high risk for transfusion-transmitted CMV infection.
CMV resides primarily in leukocytes, so leukocyte reduction (leukodepletion) effectively reduces transmission risk. Due to the high prevalence of CMV seropositivity (40–60%) in donors, relying solely on CMV-seronegative blood is impractical. Therefore, most neonatal units prefer leukocyte-reduced blood products.
Although CMV-seronegative blood may be used, it has limitations such as availability and potential dilution of infant antibodies in large transfusions, possibly increasing susceptibility to infection.
A monochorionic twin pregnancy is being evaluated for suspected twin-to-twin transfusion syndrome (TTTS). Which of the following ultrasound findings best fulfills the diagnostic criteria for TTTS?
---
- (A) Oligohydramnios in one twin (deepest vertical pocket <2 cm) and polyhydramnios in the co-twin (deepest vertical pocket >8 cm), regardless of the presence of other etiologies for fluid discordance
- (B) Oligohydramnios in one twin (deepest vertical pocket <2 cm) and polyhydramnios in the co-twin (deepest vertical pocket >8 cm), specifically in the absence of other causes of discordant amniotic fluid volumes
- (C) Oligohydramnios in one twin (deepest vertical pocket <2.5 cm) and polyhydramnios in the co-twin (deepest vertical pocket >8 cm) in monochorionic twins
- (D) Oligohydramnios in one twin with deepest vertical pocket <2 cm and polyhydramnios >7 cm in the co-twin with associated growth discordance
💡 Click to Reveal Answer & Nelson Rationale
Option B (Oligohydramnios in one twin (deepest vertical pocket <2 cm) and polyhydramnios in the co-twin (deepest vertical pocket >8 cm), specifically in the absence of other causes of discordant amniotic fluid volumes)
**The true diagnostic criteria for TTTS require:**
Oligohydramnios (<2 cm) in donor twin
Polyhydramnios (>8 cm) in recipient twin
Exclusion of other causes of discordant amniotic fluid
**The key distinction:**
Option A → ignores other causes → incomplete and incorrect
Option B → explicitly excludes other causes → correct diagnostic definition
A fetus is diagnosed antenatally with alpha-thalassemia major. The parents opt to continue the pregnancy. Serial ultrasounds demonstrate progressive fetal anemia with early features of hydrops. Which of the following is the most appropriate intervention to optimize fetal survival and perinatal outcome in this setting?
---
- (A) Early planned delivery with immediate packed red blood cell transfusions with supportive care
- (B) Expectant management with planned postnatal packed red blood cell transfusions with supportive care
- (C) Intrauterine administration of hematopoietic growth factors to enhance endogenous erythropoiesis and intrauterine packed red blood cell transfusions
- (D) Serial intrauterine packed red blood cell transfusions with continuation of transfusion support after birth
💡 Click to Reveal Answer & Nelson Rationale
Option D (Serial intrauterine packed red blood cell transfusions with continuation of transfusion support after birth)
In alpha-thalassemia major, severe fetal anemia results from absence of functional hemoglobin, leading to progressive hypoxia and hydrops fetalis. The most effective intervention when pregnancy is continued is serial intrauterine packed red blood cell transfusions, which directly correct fetal anemia, improve oxygen delivery, and allow prolongation of gestation. These transfusions must be given at regular intervals and are followed by continued transfusion support after birth. This approach improves immediate neonatal outcomes, although long-term complications may still occur.
A term infant born to parents with beta-thalassemia trait is asymptomatic at birth. The pediatrician counsels the family regarding the expected timing of onset of clinical manifestations if the child has beta-thalassemia major.
At what age do clinical features of beta-thalassemia typically begin to appear?
---
- (A) Around 8 weeks of age
- (B) Around 12 weeks of age
- (C) Around 20 weeks of age
- (D) Around 24 weeks of age
💡 Click to Reveal Answer & Nelson Rationale
Option B (Around 12 weeks of age)
Beta-thalassemia major is not clinically evident at birth because fetal hemoglobin (HbF, α2γ2) predominates during the neonatal period and does not require beta globin chains. After birth, there is a physiologic switch from gamma to beta globin synthesis. By approximately 12 weeks (around 3 months), HbF levels decline sufficiently and HbA production becomes necessary, unmasking the beta globin deficiency. This leads to ineffective erythropoiesis and anemia, resulting in clinical manifestations. The timing of symptom onset is therefore determined by the decline of HbF and rise of HbA.
A 4-month-old infant presents with transfusion-dependent anemia, failure to thrive, and evidence of pancreatic dysfunction. Which of the following is NOT a typical clinical feature of this mitochondrial disorder?
---
- (A) Muscle dysfunction
- (B) Severe neurological symptoms
- (C) Proximal tubular insufficiency
- (D) Thyroid dysfunction
💡 Click to Reveal Answer & Nelson Rationale
Option D (Thyroid dysfunction)
Pearson syndrome is a mitochondrial disorder characterized by transfusion-dependent anemia, pancreatic dysfunction, and proximal renal tubular insufficiency. The disease evolves over time, with survivors developing muscle dysfunction and severe neurological impairment due to progressive mitochondrial dysfunction. These features are well-recognized components of the syndrome. Thyroid dysfunction, however, is not a characteristic or defining feature of Pearson syndrome, making it the correct “except” option.
A neonate with symptomatic polycythemia is planned for partial exchange transfusion. The clinician calculates exchange volume using hematocrit values and estimated blood volume.
Which of the following correctly represents the formula for calculating exchange volume?
---
- (A) Exchange volume = (Observed Hct − Desired Hct) × BV (mL/kg) × weight (kg) / Observed Hct
- (B) Exchange volume = (Observed Hct − Desired Hct) / Observed Hct × BV (mL/kg) × weight (kg)
- (C) Exchange volume = (Observed Hct − Desired Hct) / BV (mL/kg) × weight (kg) × Observed Hct
- (D) Exchange volume = (Observed Hct − Desired Hct × BV (mL/kg)) / Observed Hct × weight (kg)
💡 Click to Reveal Answer & Nelson Rationale
Option A (Exchange volume = (Observed Hct − Desired Hct) × BV (mL/kg) × weight (kg) / Observed Hct)
The correct formula for partial exchange transfusion is:
Exchange volume = (Observed Hct − Desired Hct) × Blood volume (mL/kg) × weight (kg) / Observed Hct.
This can also be expressed equivalently as a fraction:
(Observed − Desired) / Observed × BV × weight.
The key concept is that the difference in hematocrit is normalized to observed hematocrit, and then multiplied by total blood volume.
A preterm neonate with a history of umbilical arterial catheterization develops progressive lower limb hypoperfusion on day 3 of life. The infant is noted to have diminished femoral pulses, cool lower extremities, and new-onset systemic hypertension. There is no murmur, and upper limb pulses are normal. Imaging is performed as shown. What is the most likely diagnosis?
---
- (A) Coarctation of aorta
- (B) Aortic thrombosis
- (C) Renal artery thrombosis
- (D) Patent ductus arteriosus with steal
💡 Click to Reveal Answer & Nelson Rationale
Option B (Aortic thrombosis)
This scenario is designed to mimic coarctation but includes key clues suggesting an acquired thrombotic event. The presence of an umbilical arterial catheter is a major risk factor for aortic thrombosis due to endothelial injury and altered flow. The combination of diminished femoral pulses with preserved upper limb pulses and systemic hypertension due to renal hypoperfusion closely resembles coarctation; however, the acute onset and catheter history favor thrombosis. The image demonstrates an intraluminal filling defect within the aorta, confirming thrombus formation rather than fixed narrowing. Renal artery thrombosis would primarily present with renal dysfunction rather than global lower limb hypoperfusion, and PDA does not cause obstructive flow patterns.
Refer to the graph depicting MCV (upper panel) and MCH (lower panel) across gestational ages (22–42 weeks). A neonate born at 30 weeks gestation has an MCV of 110 fL and MCH of 36 pg on day 1 of life. The clinician interprets these values using term reference ranges.
Which of the following is the most appropriate interpretation?
---
- (A) Microcytic normochromic pattern relative to neonatal cutoffs, suggesting early iron-restricted erythropoiesis
- (B) Normocytic indices for a term neonate but relatively decreased for gestational age
- (C) Values appropriate for gestational age but would be considered relatively macrocytic and hyperchromic if compared with term standards
- (D) True normocytic normochromic indices irrespective of gestational age, as neonatal RBC indices do not vary with maturity
💡 Click to Reveal Answer & Nelson Rationale
Option C (Values appropriate for gestational age but would be considered relatively macrocytic and hyperchromic if compared with term standards)
From the graph:
- MCV and MCH decrease with increasing gestational age
- Preterm infants (30 weeks) normally have higher MCV and MCH compared to term infants
![[857c8166_1776165876967_1776165880.png]]
Thus:
- MCV 110 fL and MCH 36 pg are appropriate for a preterm infant
- However, when incorrectly compared to term values, they may appear relatively macrocytic and hyperchromic
The trap is misuse of term reference ranges instead of gestational age–specific norms.
A 28-week gestation fetus with Rh isoimmunization is being monitored with serial Doppler studies. The middle cerebral artery peak systolic velocity (MCA-PSV) is found to be progressively rising and crosses 1.5 multiples of the median (MoM). No features of hydrops are yet present.
Which of the following is the most appropriate next step in management?
---
- (A) Continue serial MCA Doppler monitoring as this represents physiological increase with gestation
- (B) Perform amniocentesis for ΔOD450 to assess severity of hemolysis
- (C) Proceed with cordocentesis for direct assessment and possible intrauterine transfusion
- (D) Plan immediate delivery irrespective of gestational age
💡 Click to Reveal Answer & Nelson Rationale
Option C (Proceed with cordocentesis for direct assessment and possible intrauterine transfusion)
This is a high-yield application of the MCA Doppler graph.
![[469494a0_1776166030299_1776166033.png]]
**Key concept from the graph:**
- MCA-PSV increases with severity of fetal anemia
- A value >1.5 MoM (Zone A) indicates moderate to severe anemia
- This threshold is used as a trigger for intervention
**Thus:**
- >1.5 MoM → perform cordocentesis
<li>Confirms fetal anemia (Hb measurement)
- Allows intrauterine transfusion if needed
</li>
**Concept:**
- MCA Doppler has replaced amniocentesis (ΔOD450)
- Delivery is avoided if fetus is preterm → intrauterine management preferred
A 2-week-old male neonate presents with jaundice and anemia following a febrile illness. Peripheral smear is shown.A 2-week-old male neonate presents with jaundice and anemia following a febrile illness. Peripheral smear is shown.
Which of the following is the most appropriate additional therapy to prevent progression of hyperbilirubinemia in this neonate?
---
- (A) Administration of intravenous immunoglobulin to attenuate Fc receptor–mediated erythrophagocytosis and reduce bilirubin load
- (B) Use of tin-mesoporphyrin to inhibit heme oxygenase activity and suppress bilirubin production from heme catabolism
- (C) Initiation of exchange transfusion with fresh RBCs to replace oxidant-sensitive erythrocytes and decrease circulating bilirubin precursors
- (D) Use of AG-348 to allosterically activate enzyme and increase ATP generation in RBCs
💡 Click to Reveal Answer & Nelson Rationale
Option B (Use of tin-mesoporphyrin to inhibit heme oxygenase activity and suppress bilirubin production from heme catabolism)
Peripheral smear (as shown in the image) demonstrates bite cells suggestive of oxidative hemolysis. The neonate is diagnosed with G6PD deficiency.
G6PD deficiency leads to impaired regeneration of reduced glutathione, rendering RBCs vulnerable to oxidative stress and resulting in hemolysis. This increases heme breakdown and bilirubin production, predisposing neonates to severe hyperbilirubinemia and kernicterus. While standard management includes phototherapy and exchange transfusion when indicated, a targeted preventive approach is inhibition of heme degradation. Tin-mesoporphyrin inhibits heme oxygenase, the rate-limiting enzyme in heme catabolism, thereby reducing bilirubin production at its source. This directly addresses the pathophysiology of bilirubin overproduction in G6PD deficiency.
A 14-day-old neonate presents with jaundice and anemia after exposure to an oxidant drug. Peripheral smear is shown.
Which of the following enzymes is primarily responsible for conversion of superoxide radicals to hydrogen peroxide in this pathway?
---
- (A) Glutathione reductase catalyzing conversion of oxidized glutathione (GSSG) to reduced glutathione (GSH)
- (B) Glutathione peroxidase catalyzing reduction of hydrogen peroxide using reduced glutathione
- (C) CuZn superoxide dismutase (SOD1) catalyzing dismutation of superoxide radicals to hydrogen peroxide
- (D) G6PD catalyzing oxidation of glucose-6-phosphate to generate NADPH
💡 Click to Reveal Answer & Nelson Rationale
Option C (CuZn superoxide dismutase (SOD1) catalyzing dismutation of superoxide radicals to hydrogen peroxide)
Peripheral smear (as shown in the image) demonstrates Heinz bodies in G6PD-deficient hemolysis (stained with supravital dye).
In red blood cells, oxidative stress leads to formation of superoxide radicals (O₂⁻), which are highly reactive and damaging. CuZn superoxide dismutase (SOD1) is the primary enzyme responsible for converting these superoxide radicals into hydrogen peroxide (H₂O₂), a less reactive but still potentially harmful species. This hydrogen peroxide is subsequently detoxified by glutathione peroxidase using reduced glutathione (GSH). In G6PD deficiency, impaired NADPH generation limits regeneration of GSH, leading to accumulation of reactive oxygen species including hydrogen peroxide, resulting in hemoglobin denaturation, Heinz body formation, membrane damage, and hemolysis. Thus, SOD1 plays a crucial upstream role in handling oxidative stress.
![[34ba8472_1776166356299_1776166359.png]]
A term neonate undergoes serial hemoglobin monitoring, and the graph (as shown) demonstrates the decline in %HbF over the first 140 days of life with corresponding rise in HbA synthesis. At approximately 60 days of life, which of the following best explains the physiologic basis for the observed steep decline in HbF levels?
---
## 📖 Reference Citations & Explanations
- (A) Transcriptional downregulation of γ-globin genes with delayed but compensatory upregulation of β-globin synthesis
- (B) Epigenetic suppression of γ-globin expression with simultaneous induction of β-globin gene transcription
- (C) Postnatal reduction in γ-chain synthesis due to decreased erythropoietic drive and relative increase in β-chain incorporation
- (D) Preferential replacement of γ-chain–containing erythrocytes by β-chain–rich reticulocytes secondary to marrow maturation
💡 Click to Reveal Answer & Nelson Rationale
Option B (Epigenetic suppression of γ-globin expression with simultaneous induction of β-globin gene transcription)
![[cc2d1048_1776336996850_1776336997.png]]
The graph demonstrates a characteristic postnatal decline in HbF, with a relatively steep fall around 6–10 weeks of age. This reflects the developmental hemoglobin switch, which is primarily regulated at the gene expression level. The key mechanism is epigenetic silencing of γ-globin genes and activation of β-globin gene transcription, resulting in newly produced erythrocytes containing HbA instead of HbF. The decline seen in the graph is therefore due to a shift in globin synthesis rather than destruction or replacement of existing erythrocytes. The timing and slope of the curve directly correspond to this regulated transcriptional switch.